{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T19:07:01Z","timestamp":1787425621944,"version":"build-2736575974"},"reference-count":38,"publisher":"American Medical Association (AMA)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Neurol"],"published-print":{"date-parts":[[2021,9,1]]},"DOI":"10.1001\/jamaneurol.2021.2249","type":"journal-article","created":{"date-parts":[[2021,7,26]],"date-time":"2021-07-26T15:35:48Z","timestamp":1627313748000},"page":"1128","source":"Crossref","is-referenced-by-count":19,"title":["Seizure Prophylaxis After Spontaneous Intracerebral Hemorrhage"],"prefix":"10.1001","volume":"78","author":[{"given":"Felipe J. S.","family":"Jones","sequence":"first","affiliation":[{"name":"Department of Neurology, Massachusetts General Hospital, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula R.","family":"Sanches","sequence":"additional","affiliation":[{"name":"Department of Neurology, Massachusetts General Hospital, Boston"},{"name":"Department of Critical Care Medicine, Hospital Israelita Albert Einstein, S\u00e3o Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason R.","family":"Smith","sequence":"additional","affiliation":[{"name":"Department of Neurology, Massachusetts General Hospital, Boston"},{"name":"Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahar F.","family":"Zafar","sequence":"additional","affiliation":[{"name":"Department of Neurology, Massachusetts General Hospital, Boston"},{"name":"Department of Neurology, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Blacker","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts"},{"name":"Department of Psychiatry, Massachusetts General Hospital, Boston"},{"name":"Department of Psychiatry, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Hsu","sequence":"additional","affiliation":[{"name":"Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts"},{"name":"Mongan Institute for Health Policy, Department of Medicine, Massachusetts General Hospital, Boston"},{"name":"Department of Medicine, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee H.","family":"Schwamm","sequence":"additional","affiliation":[{"name":"Department of Neurology, Massachusetts General Hospital, Boston"},{"name":"Department of Neurology, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph P.","family":"Newhouse","sequence":"additional","affiliation":[{"name":"Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts"},{"name":"Department of Health Policy and Management, Harvard T. H. Chan School of Public Health, Boston, Massachusetts"},{"name":"Harvard Kennedy School, Cambridge, Massachusetts"},{"name":"National Bureau of Economic Research, Cambridge, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael B.","family":"Westover","sequence":"additional","affiliation":[{"name":"Department of Neurology, Massachusetts General Hospital, Boston"},{"name":"Department of Neurology, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidia M. V. R.","family":"Moura","sequence":"additional","affiliation":[{"name":"Department of Neurology, Massachusetts General Hospital, Boston"},{"name":"Department of Neurology, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"20","key":"noi210037r1","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1212\/WNL.0b013e31823648a6","article-title":"Early seizures in intracerebral hemorrhage: incidence, associated factors, and outcome.","volume":"77","author":"De Herdt","year":"2011","journal-title":"Neurology"},{"issue":"6","key":"noi210037r2","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1161\/STROKEAHA.117.020178","article-title":"Population-based assessment of the long-term risk of seizures in survivors of stroke.","volume":"49","author":"Merkler","year":"2018","journal-title":"Stroke"},{"issue":"9","key":"noi210037r3","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1212\/01.WNL.0000063316.47591.B4","article-title":"Acute seizures after intracerebral hemorrhage: a factor in progressive midline shift and outcome.","volume":"60","author":"Vespa","year":"2003","journal-title":"Neurology"},{"issue":"7","key":"noi210037r4","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1161\/STROKEAHA.114.004686","article-title":"The CAVE score for predicting late seizures after intracerebral hemorrhage.","volume":"45","author":"Haapaniemi","year":"2014","journal-title":"Stroke"},{"issue":"7","key":"noi210037r5","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1161\/STR.0000000000000069","article-title":"Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association.","volume":"46","author":"Hemphill","year":"2015","journal-title":"Stroke"},{"issue":"12","key":"noi210037r6","doi-asserted-by":"publisher","first-page":"3532","DOI":"10.1161\/STROKEAHA.115.010875","article-title":"Prophylactic antiepileptic drug use and outcome in the ethnic\/racial variations of intracerebral hemorrhage study.","volume":"46","author":"Sheth","year":"2015","journal-title":"Stroke"},{"issue":"4","key":"noi210037r7","doi-asserted-by":"crossref","DOI":"10.1016\/j.jstrokecerebrovasdis.2019.104628","article-title":"Why physicians prescribe prophylactic seizure medications after intracerebral hemorrhage: an adaptive conjoint analysis.","volume":"29","author":"Pinto","year":"2020","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"9","key":"noi210037r8","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1179\/1743132813Y.0000000197","article-title":"Survey of prophylactic antiseizure drug use for non-traumatic intracerebral hemorrhage.","volume":"35","author":"Jensen","year":"2013","journal-title":"Neurol Res"},{"issue":"10","key":"noi210037r9","doi-asserted-by":"publisher","first-page":"2666","DOI":"10.1161\/STROKEAHA.116.012410","article-title":"Review of the utility of prophylactic anticonvulsant use in critically ill patients with intracerebral hemorrhage.","volume":"47","author":"Gilmore","year":"2016","journal-title":"Stroke"},{"issue":"12","key":"noi210037r10","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1001\/jamaneurol.2017.2459","article-title":"Association of an electroencephalography-based risk score with seizure probability in hospitalized patients.","volume":"74","author":"Struck","year":"2017","journal-title":"JAMA Neurol"},{"issue":"3","key":"noi210037r11","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1007\/s12028-020-00939-x","article-title":"Validation of the 2HELPS2B seizure risk score in acute brain injury patients.","volume":"33","author":"Moffet","year":"2020","journal-title":"Neurocrit Care"},{"key":"noi210037r12"},{"issue":"2","key":"noi210037r13","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1097\/WNP.0000000000000166","article-title":"Consensus statement on continuous EEG in critically ill adults and children, part I: indications.","volume":"32","author":"Herman","year":"2015","journal-title":"J Clin Neurophysiol"},{"issue":"10","key":"noi210037r14","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1046\/j.1528-1157.2002.00302.x","article-title":"Seizures after spontaneous supratentorial intracerebral hemorrhage.","volume":"43","author":"Passero","year":"2002","journal-title":"Epilepsia"},{"issue":"4","key":"noi210037r15","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1159\/000342669","article-title":"Levetiracetam versus carbamazepine in patients with late poststroke seizures: a multicenter prospective randomized open-label study (EpIC Project).","volume":"34","author":"Consoli","year":"2012","journal-title":"Cerebrovasc Dis"},{"issue":"11","key":"noi210037r16","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1212\/01.WNL.0000167384.68207.3E","article-title":"New onset geriatric epilepsy: a randomized study of gabapentin, lamotrigine, and carbamazepine.","volume":"64","author":"Rowan","year":"2005","journal-title":"Neurology"},{"issue":"3","key":"noi210037r17","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1097\/TA.0b013e3182826e84","article-title":"A prospective multicenter comparison of levetiracetam versus phenytoin for early posttraumatic seizure prophylaxis.","volume":"74","author":"Inaba","year":"2013","journal-title":"J Trauma Acute Care Surg"},{"issue":"3","key":"noi210037r18","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.yebeh.2008.04.025","article-title":"Levetiracetam monotherapy for late poststroke seizures in the elderly.","volume":"13","author":"Kutlu","year":"2008","journal-title":"Epilepsy Behav"},{"issue":"9","key":"noi210037r19","first-page":"523","article-title":"The use of levetiracetam in monotherapy in post-stroke seizures in the elderly population.","volume":"45","author":"Garc\u00eda-Escriv\u00e1","year":"2007","journal-title":"Rev Neurol"},{"issue":"12","key":"noi210037r20","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1212\/01.WNL.0000038388.57824.B6","article-title":"Gabapentin in late-onset poststroke seizures.","volume":"59","author":"Alvarez-Sab\u00edn","year":"2002","journal-title":"Neurology"},{"issue":"9","key":"noi210037r21","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1161\/hs0901.094253","article-title":"Long-term survival and causes of death after stroke.","volume":"32","author":"Br\u00f8nnum-Hansen","year":"2001","journal-title":"Stroke"},{"issue":"4","key":"noi210037r22","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1161\/STROKEAHA.109.573543","article-title":"Quality-adjusted life expectancy (QALE) and loss of QALE for patients with ischemic stroke and intracerebral hemorrhage: a 13-year follow-up.","volume":"41","author":"Lee","year":"2010","journal-title":"Stroke"},{"key":"noi210037r23","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.yebeh.2017.12.037","article-title":"Health-related quality of life in patients with poststroke epilepsy.","volume":"80","author":"Winter","year":"2018","journal-title":"Epilepsy Behav"},{"issue":"21","key":"noi210037r24","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1001\/jama.2008.771","article-title":"Epilepsy surgery for pharmacoresistant temporal lobe epilepsy: a decision analysis.","volume":"300","author":"Choi","year":"2008","journal-title":"JAMA"},{"issue":"22","key":"noi210037r25","doi-asserted-by":"publisher","first-page":"e2032","DOI":"10.1212\/WNL.0000000000008548","article-title":"Implementation of quality measures and patient-reported outcomes in an epilepsy clinic.","volume":"93","author":"Moura","year":"2019","journal-title":"Neurology"},{"issue":"15","key":"noi210037r26","doi-asserted-by":"publisher","first-page":"e1429","DOI":"10.1212\/WNL.0000000000006319","article-title":"Antiepileptic drug treatment after an unprovoked first seizure: a decision analysis.","volume":"91","author":"Bao","year":"2018","journal-title":"Neurology"},{"issue":"7","key":"noi210037r27","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1212\/WNL.0000000000003612","article-title":"Selection of first-line therapy in multiple sclerosis using risk-benefit decision analysis.","volume":"88","author":"Bargiela","year":"2017","journal-title":"Neurology"},{"issue":"5","key":"noi210037r28","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1001\/archneurol.2010.356","article-title":"Statin use following intracerebral hemorrhage: a decision analysis.","volume":"68","author":"Westover","year":"2011","journal-title":"Arch Neurol"},{"issue":"8","key":"noi210037r29","article-title":"Pharmacological treatments for preventing epilepsy following traumatic head injury.","author":"Thompson","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"noi210037r30","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/s12028-009-9207-y","article-title":"Prophylactic antiepileptic drug use is associated with poor outcome following ICH.","volume":"11","author":"Mess\u00e9","year":"2009","journal-title":"Neurocrit Care"},{"issue":"12","key":"noi210037r31","doi-asserted-by":"publisher","first-page":"3810","DOI":"10.1161\/STROKEAHA.109.559948","article-title":"Anticonvulsant use and outcomes after intracerebral hemorrhage.","volume":"40","author":"Naidech","year":"2009","journal-title":"Stroke"},{"issue":"5","key":"noi210037r32","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1001\/jama.291.5.605","article-title":"The new antiepileptic drugs: scientific review.","volume":"291","author":"LaRoche","year":"2004","journal-title":"JAMA"},{"issue":"3","key":"noi210037r33","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s12028-012-9776-z","article-title":"Confounding by indication in retrospective studies of intracerebral hemorrhage: antiepileptic treatment and mortality.","volume":"17","author":"Battey","year":"2012","journal-title":"Neurocrit Care"},{"key":"noi210037r34","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.1111\/epi.1993.34.issue-s1","article-title":"Pathophysiological mechanisms of brain damage from status epilepticus.","volume":"34","author":"Wasterlain","year":"1993","journal-title":"Epilepsia"},{"issue":"17","key":"noi210037r35","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1212\/WNL.0b013e3182703fbc","article-title":"Absence of early epileptiform abnormalities predicts lack of seizures on continuous EEG.","volume":"79","author":"Shafi","year":"2012","journal-title":"Neurology"},{"issue":"8","key":"noi210037r36","first-page":"985","article-title":"Prognostic implications of periodic epileptiform discharges.","volume":"66","author":"Orta","year":"2009","journal-title":"Arch Neurol"},{"issue":"3","key":"noi210037r37","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.jcrc.2008.10.015","article-title":"Predictors of seizure onset after intracerebral hemorrhage and the role of long-term antiepileptic therapy.","volume":"24","author":"Garrett","year":"2009","journal-title":"J Crit Care"},{"issue":"3","key":"noi210037r38","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1111\/epi.2009.50.issue-3","article-title":"Impact of nonadherence to antiepileptic drugs on health care utilization and costs: findings from the RANSOM study.","volume":"50","author":"Faught","year":"2009","journal-title":"Epilepsia"}],"container-title":["JAMA Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/articlepdf\/2782136\/jamaneurology_jones_2021_oi_210037_1630683437.97799.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T15:19:55Z","timestamp":1631200795000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/fullarticle\/2782136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,1]]},"references-count":38,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaneurol.2021.2249","relation":{},"ISSN":["2168-6149"],"issn-type":[{"value":"2168-6149","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9,1]]}}}